Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. (Q53233486)

12 May 2018

title

Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. (English)

1 reference

12 May 2018

1 reference

William R. Markesbery

4

object named as

Markesbery WR

1 reference

12 May 2018

Mark A Lovell

1

object named as

Lovell MA

1 reference

12 May 2018

author name string

Xie C

2

1 reference

12 May 2018

Gabbita SP

3

1 reference

12 May 2018

publication date

1 February 2000

1 reference

12 May 2018

Free Radical Biology and Medicine

published in

1 reference

12 May 2018

volume

28

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

418-427

1 reference

12 May 2018

Oxidative alterations in Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Regional membrane phospholipid alterations in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Increased nuclear DNA oxidation in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Oxidative damage in Alzheimer's

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Structural and functional relations among thioredoxins of different species

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

1 reference

7 January 2021

Localization of thioredoxin in the rat brain and functional implications.

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Axoplasmic transport of thioredoxin and thioredoxin reductase in rat sciatic nerve

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Rat liver thioredoxin and thioredoxin reductase: purification and characterization

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Enzymatic reduction-oxidation of protein disulfides by thioredoxin

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Calcium, free radicals, and excitotoxic neuronal death in primary cell culture

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Enzymatic reduction of protein-bound methionine sulfoxide

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Redox regulation of fos and jun DNA-binding activity in vitro

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Presenilins, the Endoplasmic Reticulum, and Neuronal Apoptosis in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Relative contributions of thioltransferase-and thioredoxin-dependent systems in reduction of low-molecular-mass and protein disulphides

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Reduced thioredoxin: a possible physiological cofactor for vitamin K epoxide reductase. Further support for an active site disulfide

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

Alteration of intramolecular disulfides in insulin receptor/kinase by insulin and dithiothreitol: insulin potentiates the apparent dithiothreitol-dependent subunit reduction of insulin receptor

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(99)00258-0

7 January 2021

10.1016/S0891-5849(99)00258-0

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018